Correlation of radiological and histopathological response after neoadjuvant radiotherapy in soft tissue sarcoma

Authors

  • Sophie J. M. Reijers a Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Nicolò Gennaro b Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Annemarie Bruining b Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Hester van Boven c Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Petur Snaebjornsson c Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Elise M. Bekers c Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Frits van Coevorden a Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Astrid N. Scholten d Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Yvonne Schrage a Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Winette T. A. van der Graaf e Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Rick L. M. Haas d Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Winan J. van Houdt a Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands

DOI:

https://doi.org/10.1080/0284186X.2023.2166427

Keywords:

Sarcoma, neoadjuvant radiotherapy;, response evaluation, radiological response, histopathologic response

Abstract

Background

The aim of this study was to assess the association between radiological and histopathological response after neoadjuvant radiotherapy (nRT) in soft tissue sarcoma (STS), as well as the prognostic value of the different response evaluation methods on the oncological outcome.

Methods

A retrospective cohort of patients with localized STS of the extremity and trunk wall, treated with nRT followed by resection were included. The radiological response was assessed by RECIST 1.1 (RECIST) and MR-adapted Choi (Choi), histopathologic response was evaluated according to the EORTC-STBSG recommendations. Oncological outcome parameters of interest were local recurrence-free survival (LRFS), disease metastases-free survival (DMFS), and overall survival (OS).

Results

For 107 patients, complete pre- and postoperative pathology and imaging datasets were available. Most tumors were high-grade (77%) and the most common histological subtypes were undifferentiated pleomorphic sarcoma/not otherwise specified (UPS/NOS, 40%), myxoid liposarcoma (MLS, 21%) and myxofibrosarcoma (MFS, 16%). When comparing RECIST to Choi, the response was differently categorized in 58%, with a higher response rate (CR + PR) with Choi. Radiological responders showed a significant lower median percentage of viable cells (RECIST p = .050, Choi p = .015) and necrosis (RECIST p < .001), and a higher median percentage of fibrosis (RECIST p = .005, Choi p = .008), compared to radiological non-responders (SD + PD). RECIST, Choi, fibrosis, and viable cells were not significantly associated with altered oncological outcome, more necrosis was associated with poorer OS (p = .038).

Conclusion

RECIST, Choi and the EORTC-STBSG response score show incongruent results in response evaluation. The radiological response was significantly correlated with a lower percentage of viable cells and necrosis, but a higher percentage of fibrosis. Apart from necrosis, radiological nor other histopathological parameters were associated with oncologic outcomes.

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2023-02-01

How to Cite

Reijers, S. J. M., Gennaro, N., Bruining, A., van Boven, H., Snaebjornsson, P., Bekers, E. M., … van Houdt, W. J. (2023). Correlation of radiological and histopathological response after neoadjuvant radiotherapy in soft tissue sarcoma. Acta Oncologica, 62(1), 25–32. https://doi.org/10.1080/0284186X.2023.2166427